OXYTOCIC PHARMACEUTICALS MARKET ANALYSIS

Oxytocic Pharmaceuticals Market, By Indication (Abortion Induced Incomplete, Inevitable Abortion, Postpartum Hemorrhage, Labor Induction, and Labor Arrest), By Route of Administration (Intramuscular, and Intravenous Injection/Infusion), By Source of Origin (Synthetic Oxytocin, and Natural Oxytocin (Animal Pituitary Extract)), By End User (Hospitals, and Maternity Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

Published In : Jun 2023
Code : CMI3354
Pages :160
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Oxytocic Pharmaceuticals Market: Key Developments

On May 22 2023, Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that it has entered into a research collaboration agreement to evaluate the effect of TNX-1900 (intranasal potentiated oxytocin) on capsaicin- or electrical stimulation-induced forehead dermal blood flow in healthy female human volunteers.

On May 15 2023, Monash University is collaborating with Iconovo AB, a Research & Development company that develops and commercializes adjuvants and vaccine to develop an inhalable, preventive oxytocin treatment that aims to provide effective protection against these bleedings. Iconovo AB announced that Monash has started a clinical phase I study with the treatment in Melbourne. In addition, the product is featured in Designing Motherhood, an international design exhibition. Måns Österberg at Iconovo tells us more about the project.

In May 2022, the Central government of India allowed the import of oxytocin reference standards for testing and analysis after submitting a test license issued by the Drugs Controller General of India (DCGI).

Oxytocic Pharmaceuticals Market Report Snapshots